In this study, we describe an ordered formation of long-and very long-chain ceramide species in relation to the progression of B-cell receptor (BcR) triggering induced apoptosis. An early and caspase-independent increase in long-chain ceramide species, in which C 16 -ceramide predominated, was observed 6 h after BcR triggering. In contrast, very long-chain ceramide species were generated later, 12-24 h after BcR triggering. The formation of these very long-chain ceramide species, in which C 24 -ceramide predominated, required the activation of effector caspases. BcR-induced formation of long-chain ceramide species resulted in proteasomal activation and degradation of XIAP and subsequent activation of effector caspases, demonstrating an important cell-biological mechanism through which longchain ceramides may be involved in the progression of BcR triggering induced apoptosis and subsequent formation of very long-chain ceramide species. BcR-induced activation of the proteasome was blocked with ISP-1/myriocin, a potent and selective inhibitor of serine palmitoyl transferase that catalyzes the first and rate-limiting step in the de novo formation of ceramide. Both ISP-1 and clasto-lactacystin ␤-lactone, an irreversible inhibitor of the proteasome, prevented BcR crosslinking-induced XIAP degradation. Also, a mutant XIAP lacking the ubiquitin-ligating ring finger motif was completely resistant to proteasome-mediated degradation, and Ramos cells overexpressing XIAP became highly resistant to BcR cross-linking-induced activation of caspases. The formation of C 16 -ceramide in response to BcR cross-linking was found unaltered in XIAP overexpressing Ramos cells, whereas C 24 -ceramide formation was completely abolished. These results demonstrate how de novo generated long-chain ceramide species may be involved in the activation of downstream effector caspases and subsequent formation of very long-chain ceramide species. As such, these results provide novel and important insights into the significance of specific ceramide species in defined stages of apoptosis.
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initiates an apoptotic program known as activation-induced cell death (AICD). AICD serves to protect the body from the outgrowth of autoreactive immune cells and, as such, plays a key role in the maintenance of immune homeostasis. BcRinduced AICD is initiated as part of a complex signaling cascade in which multiple molecular components participate upon recognition of specific antigens. These signaling moieties comprise both positive and negative regulators of B-cell mitogenesis and survival, but in the absence of adequate rescue signals, they will generally skew the cells into the activation of a cell death program (1) (2) (3) (4) . BcR-induced apoptosis has been shown to involve the formation of ceramide, a bioactive lipid involved in coordinating the cellular response to various stress signals (5) (6) (7) (8) (9) (10) (11) .
Ceramide is generated de novo from the condensation of L-serine and palmitoyl-CoA followed by an acylation reaction of the resulting sphinganine and subsequent reduction of the product dihydroceramide to ceramide. The term ceramide is often used as a generic term for the many different cellular ceramide species present. These are distinguished by the degree of saturation, fatty acyl chain length, and (␣)-hydroxylation of the N-linked fatty acids. In addition, specific ceramide species may reside preferentially at topologically distinct cellular locations, which may relate to the intracellular location of specific enzymes involved in the metabolism of ceramide (10, 12) .
To date, very little is known on the differential regulation of specific ceramide species and how this contributes to the regulation of specific cell-biological events. In Ramos B-cells, we recently described that ceramide accumulation after BcR crosslinking is biphasic with an early rise in de novo derived C 16 ceramide followed by the formation of both C 16 -and C 24 -ceramide after prolonged stimulation (5) . Although mitochondria were found to be involved in the BcR-induced ceramide formation, molecular targets of the ceramides generated upon BcR cross-linking remain unknown. One recently described mechanism by which ceramide may regulate cellular responses is through the activation of a ubiquitin-dependent protein degradation pathway (13, 14) .
Cellular protein degradation by the proteasome is a strictly regulated process in which tagging of proteins with ubiquitin is the committing step for their degradation by this 26 S multicatalytic protease (15, 16) . The proteasome plays a crucial role in cellular homeostasis, regulating the cellular life span of proteins involved in phenomena such as cell activation, cell cycle progression, and apoptosis (17, 18) . Proteasome activation linked to the degradation of anti-apoptotic proteins such as Bcl-2 and XIAP has been described as an early event in various forms of programmed cell death (18 -23) . In addition, the disruption of sphingolipid formation through the de novo pathway of sphingolipid biosynthesis has been shown to prevent ubiquitindependent proteolysis during heat stress in Saccharomyces cerevisiae (13) . Thus, de novo derived sphingolipids may be regulating the life span of specific proteins that are prone to degradation by the 26 S proteasome. Moreover, because many of the proteins involved in cellular homeostasis have been described to be subject to degradation by the proteasome, sphingolipid-mediated regulation of proteasomal activity may provide cells with an attractive means to regulate various aspects of cellular homeostasis including cell activation, cell cycle progression, and apoptosis.
In this study, we demonstrate that ceramide formation in response to BcR cross-linking is a highly ordered process in that specific long-chain ceramide species are generated early and independent from effector caspase activation, whereas very long-chain ceramide species are generated relatively late and downstream from effector caspase activation. In addition, it is shown that the early formation of long-chain ceramide species is linked to proteasomal degradation of XIAP and subsequent activation of effector caspases, which demonstrates an important cell-biological mechanism through which long-chain ceramide species may be involved in the activation of effector caspases and subsequent formation of very long-chain ceramide species.
MATERIALS AND METHODS

Cell Culture
The Epstein-Barr virus-negative Burkitt's lymphoma Ramos cells were purchased from ATCC (Manassas, VA) and grown in RPMI 1640 medium supplemented with 25 mM Hepes, 10% fetal calf serum, 2 mM L-glutamine (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 100 units/ml penicillin (Invitrogen), and 100 g/ml streptomycin (Invitrogen) under standard incubator conditions (humidified atmosphere, 95% air, 5% CO 2 , 37°C).
Reagents
Polyclonal rabbit anti-PARP antibody and peroxidase-conjugated anti-rabbit antibody were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-XIAP was purchased from R&D Systems Inc. (Minneapolis, MN) ; anti-caspase-3 was purchased from BD Biosciences; and anti-actin was purchased from ICN Biomedicals (Zoetermeer, The Netherlands). ISP-1 and ribonuclease A were purchased from Sigma. Suc-Leu-Leu-Val-Tyr-7-AMC was obtained from Bachem AG (Bubendorf, Switzerland). Propidium iodide and DiOC 6 were purchased from Molecular Probes (Eugene, OR). [␥-32 P]ATP was obtained from PerkinElmer Life Sciences products. zVAD-fmk (Z-Val-Ala-DL-Asp-fluoromethylketone) was from Calbiochem.
Ceramide Measurements
Diacylglycerol Kinase (DGK) Assay-Cell pellets (2.0 ϫ 10 6 ) were lysed in chloroform:methanol (1:2), and lipids were extracted by the method of Bligh and Dyer (51) . Aliquots were dried down and used for ceramide and phosphate measurements. Ceramide levels were measured using the Escherichia coli diacylglycerol kinase assay (24, 25) . Lipids were incubated at room temperature for 30 min in the presence of ␤-octylglucoside/dioleoylphosphatidylglycerol micelles, 2 mM dithiothreitol, 5 g of proteins of diacylglycerol kinase membranes, and 2 mM ATP (mixed with [␥- 32 -P]ATP) in a final volume of 100 l. Lipids were again extracted according to Bligh and Dyer. 32 P-Ceramide was determined by TLC analysis in chloroform:acetone:methanol:acetic acid:water (50:20:15:10:5) followed by scraping the ceramide doublet and counting the radioactivity by liquid scintillation. Ceramide levels were normalized to total lipid phosphate.
Tandem Mass Spectrometry-Cell pellets (2.0 ϫ 10 6 ) were lysed in chloroform:methanol (1:2), and lipids were extracted by the method of Bligh and Dyer. Aliquots were dried down and used for ceramide and phosphate measurements. For mass spectrometric analysis, we utilized normal phase high performance liquid chromatography coupled to atmospheric pressure chemical ionization (APCI) as described previously (5) . Separations were conducted using Iatrobead (Iatron Laboratories, Tokyo, Japan) beaded silica columns utilized in a normal phase of operation. Elutions were completed on a Agilent (Palo Alto, CA) model 1100 high performance liquid chromatography system equipped with a binary pumping system of iso-octane and ethyl acetate. All MS analyses were conducted on a Finnigan (Foster City, CA) LCQ ion trap mass spectrometer. For APCI-MS, the entire flow from the high performance liquid chromatography column was directed to the APCI source. For all of the experiments, source ion optics were adjusted to accomplish desolvation of ions while minimizing fragmentation of analyte ions in the inlet region of the mass spectrometer. Ceramide and dihydroceramide subspecies were identified by a combination of mass (m/z) intensity ratios in the MS fragmentation pattern and column retention. The analysis was then standardized by programming the LC-Quant software followed by manual confirmation. Quantitative analysis was made possible by the use of C 17 -ceramide as an internal standard with comparison to external calibration standards. The full details of this method have been submitted. 2 
Mitochondrial Transmembrane Potential (⌬⌿)
To evaluate changes in ⌬, cells (5 ϫ 10 5 /ml) were treated as as noted earlier. After washing and resuspension in medium without fetal bovine serum, cells were labeled with DiOC6 (0.1 M) for 25 min at 37°C. After incubation, cells were washed and analyzed directly on a flow cytometer using excitation and emission wavelengths of 495 and 525 nm, respectively.
DNA Fragmentation Analysis
DNA fragmentation was essentially performed as described previously (26). 5 ϫ 10 6 cells were labeled with 1 Ci/ml [ 3 H]thymidine at 37°C, 5% CO 2 overnight for 18 h. Cells were then washed three times with culture medium to remove excess free label. 1 ϫ 10 4 cells were plated in a round bottom 96-well plate (Corning Life Sciences, SchipholRijk, The Netherlands) in 100 l of culture medium and treated as described (26) at 37°C, 5% CO 2 for 24 h. Samples were then harvested onto fiberglass filters retaining non-fragmented DNA. Radioactivity was measured by standard liquid scintillation counting.
Gel Electrophoresis
1 ϫ 10 6 cells were treated as described and lysed in 90 l of lysis buffer containing 0.5% N-lauroyl sarcosine (Sigma), 0.5 mg/ml RNase (Sigma), 1 mg/ml proteinase K (Invitrogen) in 50 mM Tris-HCl, pH 8, and incubated at 50°C for 2 h. Samples were then sheared by 10 strokes through a 25-gauge needle, and the concentration of DNA per sample was determined by UV at A 260 /A 280 nm to allow equal sample loading. DNA laddering was visualized by UV after separation at 100 V on a 1.5% agarose gel.
Cloning and Expression of XIAP Mutants in Ramos
Wild type XIAP (XIAP wt ) and RING-less XIAP (XIAP⌬ R ) were cloned from Ramos cells by reverse transcriptase-PCR using the following primers (Biolegio, Malden, The Netherlands). Forward primer for both XIAP wt and XIAP⌬ R was 5Ј-ATCTCGAGATGACTTTTAACAGTTTTG-AA-3Ј. Reverse primer XIAP wt was 5Ј-ATGCGGCCGCACATGCCTAC-TATAGAGTTAG-3Ј. Reverse primer for XIAP⌬ R was 5Ј-ATGCGGCC-GCACACTCCTCAAGTGAATGAGT-3Ј. PCR products were subcloned in the pCR4Blunt-TOPO vector (Invitrogen) and then subcloned into the retroviral LZRS-pBMN-IRES-EGFP (kindly provided by H. Spits, NKI, The Netherlands), which was constructed from the LZRS-LacZ(A) originally described by Kinsella and Nolan (27) 
Western Blot Analysis
Cells were lysed for 15 min on ice in lysis buffer (20 mM Tris-HCl, 5 mM EDTA, 2 mM EGTA, 100 mM NaCl, 0.05% SDS, 0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotein, and 10 g/ml leupeptin). Lysates were centrifuged at 10,000 rpm for 10 min and mixed with reducing SDS sample buffer. Proteins (10 g as determined by Bio-Rad protein assay) were separated by SDS-polyacrylamide gel electrophoresis. Proteins were transferred to nitrocellulose membranes (Bio-Rad), which were subsequently blocked by 5% nonfat dry milk in phosphate-buffered saline-Tween 20 (0.1%, v/v). Blots were incubated with anti-PARP (1:1000 dilution, 1 h), anti-XIAP (1:200 dilution, 4 h), anti-active caspase-3 (1:1000 dilution, 1 h), or anti-actin (1:4000 dilution, 2 h) in 5% nonfat dry milk. After subsequent incubation with a 1:2000 dilution of horseradish peroxidase anti-rabbit IgG (for PARP, caspase-3, and XIAP) or 1:2500 dilution of horseradish peroxidase antimouse IgG (for actin) for 1 h, proteins were visualized by ECL.
Analysis of Proteasome Activity
ϫ 10
6 cells were treated in a volume of 3 ml as noted. After treatment, cells were washed once in phosphate-buffered saline, and 1 ϫ 10 6 cells were suspended in 200 l of phosphate-buffered saline in a white flat bottom 96-well plate (Corning Life Sciences). Directly thereafter, 20 l of Suc-LLVY-7AMC (0.1 mM) was added and the plate was placed at 37°C until measurement. Substrate conversion was measured with a dual-scanning spectrofluorometer (Spectramax Gemini XS, Molecular Devices Corp., Sunnyvale, CA) using an excitation wavelength of 355 nm, measuring fluorescence at an emission wavelength of 440 with a cutoff set at 435 nm.
RESULTS
BcR Cross-linking Induces the Formation of Ceramide through the de Novo Pathway of Sphingolipid Biosynthesis-
BcR cross-linking of Ramos B-cells is associated with the formation of ceramide. This was shown using both the DGK method for quantitation of ceramide ( Fig. 1, A and B) and using normal phase high performance liquid chromatography coupled to atmospheric pressure chemical ionization (tandem mass spectrometry) (Fig. 1, C and D) . In Ramos cells, the C 16 -and C 24 -ceramide species are the predominant species (5), and the changes in their levels in response to BcR cross-linking therefore are shown specifically in Fig. 1 , C and D. An analysis of ceramide by DGK yields two ceramide spots upon separation by TLC. The upper spot corresponds to very long-chain ceramide species (C 22 -C 26 -ceramide ϩ dihydroceramides), whereas the lower spot corresponds to long-chain ceramide species (C 14 -C 20 ) (5). The early increase at 6 h after BcR cross-linking of C 16 -ceramide is seen both by DGK analysis as an increase in the lower ceramide-1-P spot upon separation by TLC (Fig. 1B) and by tandem MS analysis (Fig. 1D) . The increase in very long-chain ceramide species becomes apparent after 12-24 h of BcR cross-linking as an increase in the upper ceramide-1-P spot upon separation by TLC (Fig. 1A ) and as C 24 -ceramide by tandem MS analysis (Fig. 1C) . We have previously shown that the increase in ceramide after BcR cross-linking results from activation of the de novo pathway of sphingolipid biosynthesis (5) . Indeed, ISP-1, a potent inhibitor of serine palmitoyltransferase, which catalyzes the first and rate-limiting step in the de novo pathway of sphingolipid biosynthesis, blocked ceramide formation.
BcR Cross-linking Activates the 26 S Proteasome via de Novo Derived Sphingolipids-Recently, it was shown that sphingolipids derived via the de novo pathway of sphingolipid biosynthesis are required to induce ubiquitin-dependent proteolysis in S. cerevisiae upon heat stress (13) . In light of these results, we examined the effects of BcR cross-linking and ceramide formation in Ramos cells on proteasome activation. The treatment of Ramos cells with anti-IgM resulted in significant up- regulation of proteasomal activity as shown by enhanced substrate processing 6 h after start of the treatment (Fig. 2) . Anti-IgM-induced activation of the proteasome could be detected up to 24 h after BcR cross-linking. The induced activity of the proteasome could be blocked using clasto-lactacystin ␤-lactone (CLC), a specific inhibitor of the proteasome, affirming the specificity of the observed substrate processing by the proteasome (Fig. 2A) .
As shown in Fig. 1 , co-incubation with ISP-1 inhibits the early accumulation of ceramide upon BcR cross-linking. Moreover, as shown in Fig. 2B , ISP-1 was found to inhibit BcR cross-linking-induced proteasome activation. Thus, the formation of sphingolipids via the de novo pathway of sphingolipid biosynthesis is a required step in the activation of the proteasome upon BcR cross-linking.
XIAP Is Degraded as a Result of Sphingolipid-dependent Proteasome Activation-To further delineate the significance of the observed BcR-induced activation of the proteasome, we investigated the fate of XIAP, an anti-apoptotic protein known to be degraded in a ubiquitin proteasome-dependent manner. As shown in Fig. 3 , BcR cross-linking caused a reduction in the levels of XIAP. This was first seen 6 h after BcR cross-linking and more pronounced in cells treated for 24 h (Fig. 3A) . CLC shown to specifically inhibit proteasome activation (see also Fig. 2) prevented BcR cross-linking-induced XIAP degradation (Fig. 3A) , thus supporting a role for the proteosome in degradation of XIAP.
Ramos cells were treated next with anti-IgM in the presence of ISP-1 (Fig. 3B) or the caspase inhibitors, zVAD and IETD, (Fig. 3, C and D) to investigate the effect of inhibition of sphingolipid formation and effector caspases on XIAP stability and apoptosis. As shown in Fig. 3B , ISP-1 dose-dependently prevented BcR-induced XIAP degradation. These results are in line with the observation that ISP-1 prevented BcR cross-linking-induced activation of the proteasome (Fig. 2B) . Thus, de novo generated sphingolipids mediate the effects of BcR crosslinking on degradation of XIAP. In addition and in agreement with previous studies (28) , XIAP degradation could not be prevented using zVAD, demonstrating that XIAP degradation was independent from effector caspase activation (Fig. 3C) . Furthermore, ISP-1 prevented BcR-induced PARP cleavage when used in combination with the initiation caspase inhibitor IETD (Fig. 3D) , which has been shown previously not to be involved directly in BcR-induced mitochondrial damage (Fig.  3D) (4, 29) .
Overexpression of a Degradation-resistant XIAP Confers Resistance to Specific Aspects of BcR-induced Apoptosis-The role of XIAP in BcR cross-linking-induced apoptosis and its relation to sphingolipid-mediated degradation through the proteasome was further investigated. To this end, we constructed a XIAP lacking the RING domain, XIAP⌬ R , by reverse transcriptase-PCR from Ramos cells as described by Yang et al. (19) (Fig. 4A) . The C-terminal RING domain is a required element of XIAP for ubiquitination and proteasome-mediated degradation. In contrast, the anti-apoptotic properties of XIAP reside in the three BIR domains with the BIR2 domain being sufficient to inhibit caspases-3 and -7 and the BIR3 domain being sufficient to block caspase-9 activation (30, 31).
XIAP wt -or XIAP⌬ R -expressing sublines of Ramos were established as described under "Materials and Methods." Western blot analysis of Ramos-XIAP⌬ R and Ramos XIAP wt revealed overexpression of the wild type 57-kDa XIAP in Ramos-XIAP wt cells, whereas Ramos-XIAP⌬ R showed overexpression of a 40-kDa protein, corresponding to the estimated molecular mass of the RING-less XIAP protein (Fig. 4B ). In addition, whereas both endogenous XIAP and the XIAP wt were subject to BcR cross-linking-induced degradation, XIAP⌬ R was found to be totally resistant toward degradation after BcR cross-linking. Because the RING domain has been described to mediate in the ubiquitination of XIAP, thus tagging it for degradation by the proteasome, these results confirm the involvement of the ubiquitin proteasome pathway in XIAP degradation upon BcR cross-linking.
The significance of XIAP as an anti-apoptotic protein in B-cell homeostasis was investigated next. To this end, Ramos, Ramos-XIAP wt , and Ramos-XIAP⌬ R cells were treated with anti-IgM and various characteristic aspects of apoptosis were measured. As shown in Fig. 5A , BcR cross-linking-induced PARP-cleavage was significantly reduced in Ramos-XIAP wt cells and even more so in Ramos-XIAP⌬ R cells. Also, in Fig. 5A , it is shown that the activation of caspase-3 was significantly reduced in Ramos-XIAP wt cells and virtually undetectable in Ramos-XIAP⌬ R cells. In addition to cleavage of PARP, caspase-3 directly activates endonucleases resulting in the fragmentation of nuclear DNA. The JAM assay provides a convenient way to quantify fragmentation of cellular DNA dur-
FIG. 2. BcR cross-linking is associated with sphingolipid-dependent activation of the proteasome. Ramos cells (5 ϫ 10
5 /ml) were treated with anti-IgM (10 g/ml) for 6 or 24 h in the presence or absence of the proteasome inhibitor CLC (5 M) (A) or ISP-1 (10 nM) (B) in 5% CO 2 at 37°C. Proteasome activity was analyzed in live cells (1 ϫ 10 6 ) 2 h after addition of the proteasome substrate Suc-LLVY-7-AMC (0.1 mM) as described under "Materials and Methods." Inset, kinetics of proteasomal substrate conversion after the addition (T ϭ 0 h) of substrate following treatment for 6 h with anti-IgM. Data (mean Ϯ S.E.) are from one of three experiments performed in duplicate.
ing apoptosis. Quantification of DNA fragmentation by this method has been shown to correlate well with the percentage of apoptotic cells (26) and various other markers of apoptosis (32) . As shown in Fig. 5B , both XIAP wt and XIAP⌬ R conferred resistance toward BcR cross-linking-induced DNA fragmentation with the degradation-resistant XIAP⌬ R being slightly more effective compared with XIAP wt . Similar clear results were obtained by direct visualization of DNA laddering using agarose gel electrophoresis (data not shown). Taken together, these results demonstrate that indeed 1) XIAP is actively involved in protecting against BcR cross-linking-induced apoptosis and 2) degradation of XIAP is required for the activation of the caspase-mediated apoptotic program in response to BcR cross-linking.
Because XIAP-mediated protection against BcR cross-linking-induced apoptosis occurs at the level of caspases, we also determined mitochondrial damage in response to BcR crosslinking, which is proximal to caspase activation in BcR crosslinking-induced apoptosis. As shown in Fig. 5C , the overexpression of neither XIAP wt nor XIAP⌬ R protected against early mitochondrial damage. After the first 6 h of treatment, an approximately 2-fold induction of mitochondrial damage was observed in Ramos, Ramos-XIAP wt , and Ramos-XIAP⌬ R cells (Fig. 5, C and E) . In contrast, 24 h after treatment, mitochondrial damage in Ramos cells further increased 8-fold, whereas XIAP wt and XIAP⌬ R significantly protected against further mitochondrial damage. This is consistent with a caspase-mediated feedback loop, enhancing mitochondrial damage and the effector-phase of BcR cross-linking-induced apoptosis.
Formation of C 16 -and C 24 -Ceramide Species Is Differentially Regulated Upstream and Downstream of Effector Caspases-
We previously described that early following BcR cross-linking, before signs of apoptosis associated with caspase activation are observed, long-chain ceramides with C 16 -ceramide being the predominant species are formed. At later time points (i.e. 24 h after the start of the treatment), very long-chain ceramides with C 24 -ceramide being the predominant species are formed (see also Fig. 1) .
In light of the distinct mitochondrial and caspase-dependent phases of apoptosis that had become apparent using overexpression of XIAP, we next investigated the effects of caspase inhibition by XIAP on the formation of ceramide after BcR cross-linking. To this end, we used the DGK assay in which long chain ceramide species (C 14 -C 18 ) migrate in the lower ceramide-1-P spot, whereas very long-chain ceramide species (C 20 -C 26 ) migrate in the upper ceramide-1-P spot upon separation by TLC (5). Because C 16 and C 24 are by far the predominant ceramide species present in Ramos cells (5), separation and quantification of DGK-phosphorylated ceramide species by TLC in the upper and lower spot provide an accurate measurement of specific changes in C 16 -and C 24 -ceramide after treatment. As shown in Fig. 6 , caspase inhibition using XIAP wt , XIAP⌬ R , or the pan-caspase inhibitor zVAD had no effect on 6C in the presence of zVAD) . Thus, although long-chain ceramide species, specifically C 16 -ceramide, are generated upstream of caspase activation, the formation of very long-chain ceramide species, specifically C 24 -ceramide, seem to be dependent on the activation of effector caspases. DISCUSSION We previously described the involvement of de novo derived ceramide in BcR-induced apoptosis (5) . This study was initiated to investigate the mechanisms by which specific ceramide species are generated and how these ceramide species may be involved in BcR-induced apoptosis in Ramos cells. After 6 h of FIG. 5 . XIAP overexpression protects against BcR cross-linking-induced caspase-dependent apoptotic events. Ramos, Ramos-XIAP wt , and Ramos-XIAP⌬ R cells (5 ϫ 10 5 /ml) were treated with anti-IgM (10 g/ml) or the indicated concentration of anti-IgM (B) for 24 h or the indicated time period (C-E) in 5% CO 2 at 37°C. A, cells were prepared for analysis of PARP cleavage or presence of activated caspase-3 as described under "Materials and Methods." Equal protein loading (10 g/lane) was verified using actin as a reference protein. Equal presence of total caspase-3 in all cell lines was verified using polyclonal antibodies directed against amino acids 1-277, representing the full-length precursor form of caspase-3. B, [ 3 H]thymidine prelabeled cells were used and analyzed for the induction of DNA fragmentation after treatment with the indicated concentrations of anti-IgM using the JAM assay as described under "Materials and Methods." C-E, after 6 and 24 h of treatment, cells were prepared for flow cytometrical analysis of mitochondrial damage by staining with DiOC6 (0.1 M) as described under "Materials and Methods." All results shown are representative of at least three independent experiments. stimulation prior to the detection of classical apoptosis-related phenomena such as PARP-cleavage and DNA fragmentation, BcR cross-linking is characterized by a rise in long-chain ceramide species in which C 16 -ceramide predominates. In contrast, very long-chain ceramide species in which C 24 -ceramide predominates are formed after prolonged BcR stimulation and become detectable after 24 h of stimulation. Predominant accumulation of C 16 -ceramide during apoptosis has been described previously (33) . To date, no reports are available on the regulation of this differentiated ceramide formation. In addition, it remains unclear exactly how ceramide may be involved in the progression of BcR-induced apoptosis.
Recent reports have linked sphingolipid synthesis with the activation of the ubiquitin proteasome pathway (13, 14) . Inactivation of the ubiquitin-proteasomal pathway was shown in a mutant strain of S. cerevisiae, lcb1-100, a temperature-sensitive mutant of serine palmitoyltransferase that catalyzes the first and rate-limiting step in the de novo formation of ceramide (13) . In addition, the activation of the proteasome has been described as an integral part of the initiation phase of apoptosis (19, 22, 23) . Likewise, we found increased proteasomal activity early after BcR cross-linking. In addition, blocking ceramide formation with ISP-1, a potent inhibitor of serine palmitoyltransferase (34) , inhibited the activation of the proteasome, linking the formation of ceramide through the de novo pathway of sphingolipid biosynthesis with the increased proteasomal activity. This is in line with studies showing sphingolipid-dependent modulation of the proteasome complex via phosphorylation of the C8 and C9 subunits of the proteasome complex (35) and activation of transcription of genes encoding subunits of the proteasome (36, 37). Proteasome activation does not seem to be a direct consequence of mitochondrial damage because anti-CD20-induced apoptosis, which involves mitochondrial damage without formation of ceramide, 3 does not involve proteasome activation. Activation of the ubiquitin proteasome pathway by sphingolipids is not likely to be via direct interaction because direct modulation of proteasomal activity using synthetic short-chain and long-chain ceramides in vitro was not observed (data not shown). Proteasome activation in relation to apoptosis has been well documented (18) . In addition, pharmacological blockers of proteasome function may induce apoptosis too, showing the importance of this protease complex in maintaining cellular homeostasis (38, 39) . In general, it may be postulated that the ubiquitin proteasome pathway for protein degradation is especially well suited to regulate cellular levels of short-lived proteins and to control unidirectional cellular processes such as the execution of a cell death program. The latter typically involves degradation of protective proteins such as that recently described for the anti-apoptotic protein XIAP (19, 28) .
Indeed, we observed significant degradation of XIAP in Ramos cells upon BcR cross-linking. In agreement with previously described studies, XIAP degradation was completely blocked using CLC, an irreversible and specific inhibitor of the proteasome (19, 40) . Similar results were obtained using a recently described (41) potent and selective proteasome inhibitor, AdaAhxL3VS (data not shown). Moreover, the pancaspase inhibitor zVAD could not prevent BcR-induced XIAP degradation, which is in agreement with the results described by others (19, 28) , and shows that BcR cross-linking-induced XIAP degradation is caspase-independent. In addition, BcR- induced proteasome activation appears to occur upstream of caspase activation. Indeed, BcR-induced proteasome activation was not blocked by zVAD (data not shown). The anti-apoptotic properties of XIAP reside in the BIR domains, which interact with the substrate recognition sequences of caspases-3, -7, and -9, and mask these for their cellular targets. XIAP degradation by the proteasome has been shown to involve the ubiquitinligase activity of the C-terminal RING finger domain (19, 31, 42) . Mutation analysis has shown that the removal of this domain results in a protein that is as competent as its fulllength counterpart in inhibiting apoptosis, whereas the protein itself becomes resistant to proteasomal degradation. Therefore, we overexpressed a RING-less XIAP construct in Ramos cells first to verify its stability upon BcR cross-linking and second to investigate downstream effects of stable degradation-resistant XIAP overexpression during BcR cross-linking.
We show that the RING-less XIAP, XIAP⌬ R , remains stably expressed after BcR cross-linking. Incubation over prolonged time periods with anti-IgM did not result in a noticeable diminution of XIAP⌬ R . In contrast, endogenous XIAP in these same cells as well as overexpressed wild type XIAP remained subject to degradation, which places the ubiquitin proteasome pathway as an important regulator upstream of caspase activation in BcR-induced apoptosis.
Overexpression of wild type XIAP and, even more so, overexpression of the degradation-resistant XIAP⌬ R profoundly affected the execution of BcR cross-linking-induced apoptosis. Besides ceramide formation, BcR-induced apoptosis involves mitochondrial dysfunction and caspase activation followed by cleavage of caspase-sensitive target proteins, such as PARP, and ultimately DNA fragmentation. Caspase-3 activation as well as PARP cleavage and DNA fragmentation were significantly reduced in Ramos-XIAP wt cells and virtually undetectable in Ramos-XIAP⌬ R cells. This confirms the retention of the anti-apoptotic properties of XIAP⌬ R and signifies the roles of effector caspases such as caspases-3, -7, and -9 in the execution phase of BcR-induced apoptosis. The effects of XIAP overexpression on the loss of BcR cross-linking-induced mitochondrial function displayed a more differentiated pattern. XIAP did not offer protection against early mitochondrial damage measured after treatment with anti-IgM for 6 h. However, XIAP significantly protected against BcR cross-linking-induced mitochondrial damage measured at later time points after the start of the treatment. This finding is consistent with the proposed apoptotic feedback loop, inflicting effector caspase-dependent mitochondrial damage (43) . Together with previous results showing that zVAD did not protect against initial mitochondrial damage (5), these results further underline an initiating role for mitochondria in BcR cross-linking-induced apoptosis.
Parallel with the differentiated effects of XIAP overexpression on the protection of mitochondrial damage, we found that overexpression of XIAP had profound effects on the generation of specific ceramide species after BcR cross-linking. To date, no reports exist on the differentiated regulation of specific ceramide species during apoptosis. Here we provide evidence for such a differentiated regulation upstream and downstream of effector caspases. XIAP overexpression did not abrogate the early formation of ceramide retained in the lower ceramide-1-P TLC spot, which consists of long-chain ceramide species. In contrast, XIAP overexpression completely blocked the formation of ceramide species retained in the upper ceramide-1-P TLC spot, which is normally increased at later time points (i.e. 24 h) after the start of BcR cross-linking. Ceramide species that migrate in this upper spot identified as very long-chain ceramide species (5) apparently are formed not only later in the apoptotic process but also as a result of caspase activation.
Interestingly, the differentially regulated formation of longand very long-chain ceramide species coincides with the effects of XIAP seen on mitochondrial damage and therefore appears to be linked. The source of specific ceramide species generated 24 h after BcR cross-linking remains to be investigated. Whereas both ISP-1 and fumonisin B1 (FB1) abrogate the formation of these ceramide species at 24 h, suggesting the de novo pathway of sphingolipid biosynthesis to be the main source, we cannot rule out activation of SMase enzymes or other more complex conversion reactions leading to the observed increase of ceramide 24 h after start of the treatment. SM levels do not drop significantly upon BcR stimulation (5), making the involvement of any SMase-driven form of ceramide formation unlikely. Other pools of sphingolipids that may serve as a source for ceramide include sphingosine, glycosphingolipids, and ceramide-1-phosphate. Future experiments need to clarify how effector caspase activation may lead to the activation of enzymes involved in the generation of ceramide from any of these sources.
As summarized in Fig. 7 , our results suggest the involvement of the early formation of long-chain ceramide species in the initial mitochondrial phase of apoptosis. In contrast, the very long-chain ceramide species appear to result from activated caspases and might play a role in the downstream effector phase of apoptosis. In this respect, it may be interesting to note that in the presence of ISP-1, ceramide levels initially dropped to below control values. However, at the later time points after BcR cross-linking, ISP-1 lost its ability to completely block the formation of ceramide, especially the very long-chain ceramide. This finding suggests that the total ceramide response after BcR cross-linking may be regulated in the early mitochondrial phase through the de novo pathway, although the secondarily formed very long-chain ceramide species may be differently regulated, e.g. through caspase-activated SMases or turnover of other complex sphingolipids. A combined response involving both SMase activity and de novo derived ceramide in MCF7 cells upon tumor necrosis factor-␣ treatment has recently been described (44) and may thus represent a common mode by which cellular ceramide may accumulate and exert specific effects at distinct intracellular locations.
This complexity of ceramide formation may explain many of the confusing results in the literature that attempt to place (total) ceramides at various points upstream or downstream in the apoptotic program. Our results clearly demonstrate that different ceramide species are formed with distinct kinetics by different mechanisms and participate in distinct mechanisms and phases of the apoptotic program.
The interrelation of sphingolipids and mitochondrial function has been the subject of recent interest. Studies have identified mitochondrial presence of enzymes and metabolites thereof involved in a mitochondrial network of sphingolipid metabolism (45) (46) (47) . In addition, mitochondrial targeting of bacterial SMase was the only intracellular location where transfection-induced ceramide formation positively correlated with the induction of apoptosis (47, 48) . Furthermore, BcR cross-linking has been shown to up-regulate the enzyme CPT-I, which catalyzes import of fatty acids used for ␤-oxidation into mitochondria (49) . It has been shown that the import of palmitoyl CoA, which is a prerequisite precursor for C 16 -ceramide, into mitochondria by CPT-I correlated with apoptosis (49, 50) . These studies suggest an interplay between mitochondrial ceramide and other cellular components, such as the ubiquitin proteasome pathway, in the regulation of apoptosis. In addition, they establish a strong basis for future studies to further dissect molecular mechanism underlying the generation of specific ceramide species during apoptosis and their role in the progression of apoptosis.
